82 results
DEFA14A
EVOK
Evoke Pharma Inc
10 Apr 24
Additional proxy soliciting materials
3:35pm
Statement
Definitive Additional Materials
Soliciting Material under §240.14a-12
Evoke Pharma, Inc.
(Name of Registrant as Specified in Its Charter)
(Name … previously with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
Company
424B3
EVOK
Evoke Pharma Inc
14 Mar 24
Prospectus supplement
6:44pm
of our required raw materials, drug substance and finished product for our product development and clinical trials. We currently use a third-party … deviations from FDA standards, a requirement that future advertising and promotional materials are pre-cleared by FDA, and state and federal civil
8-K
EX-1.1
hg8z5
9 Feb 24
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
5:15pm
DEFA14A
m1k1qwpzkxvwdtstt
29 Mar 23
Additional proxy soliciting materials
4:30pm
DEFA14A
2zzt5s7vno5
15 Mar 22
Additional proxy soliciting materials
4:05pm
DEFA14A
2lf9y8e
15 Mar 22
Additional proxy soliciting materials
8:35am